Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 21875585)

1.

Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.

Tsai YC, Weissman AM.

FEBS Lett. 2011 Oct 20;585(20):3166-73. doi: 10.1016/j.febslet.2011.08.031. Epub 2011 Aug 27. Review.

2.

Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.

Bari R, Zhang YH, Zhang F, Wang NX, Stipp CS, Zheng JJ, Zhang XA.

Am J Pathol. 2009 Feb;174(2):647-60. doi: 10.2353/ajpath.2009.080685. Epub 2008 Dec 30.

3.

Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.

Liu WM, Zhang F, Moshiach S, Zhou B, Huang C, Srinivasan K, Khurana S, Zheng Y, Lahti JM, Zhang XA.

PLoS One. 2012;7(12):e51797. doi: 10.1371/journal.pone.0051797. Epub 2012 Dec 14.

4.
5.

Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.

Zhang XA, He B, Zhou B, Liu L.

J Biol Chem. 2003 Jul 18;278(29):27319-28. Epub 2003 May 8.

6.

KAI1/CD82, a tumor metastasis suppressor.

Liu WM, Zhang XA.

Cancer Lett. 2006 Aug 28;240(2):183-94. Epub 2005 Nov 2. Review.

PMID:
16260083
7.

CD82 metastasis suppressor gene: a potential target for new therapeutics?

Tonoli H, Barrett JC.

Trends Mol Med. 2005 Dec;11(12):563-70. Epub 2005 Nov 3. Review.

PMID:
16271511
8.

ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion.

Wu J, Liang S, Bergholz J, He H, Walsh EM, Zhang Y, Xiao ZX.

Cell Death Dis. 2014 Jun 5;5:e1280. doi: 10.1038/cddis.2014.239.

PMID:
24901051
9.

Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.

Odintsova E, van Niel G, Conjeaud H, Raposo G, Iwamoto R, Mekada E, Berditchevski F.

J Biol Chem. 2013 Sep 6;288(36):26323-34. doi: 10.1074/jbc.M112.439380. Epub 2013 Jul 29.

10.

Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis.

Miranti CK.

Cell Signal. 2009 Feb;21(2):196-211. doi: 10.1016/j.cellsig.2008.08.023. Epub 2008 Sep 11. Review.

PMID:
18822372
11.

KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.

Park JJ, Jin YB, Lee YJ, Lee JS, Lee YS, Ko YG, Lee M.

BMC Cancer. 2012 Mar 6;12:81. doi: 10.1186/1471-2407-12-81.

12.

Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.

Scarpino S, Duranti E, Giglio S, Di Napoli A, Galafate D, Del Bufalo D, Desideri M, Socciarelli F, Stoppacciaro A, Ruco L.

Thyroid. 2013 Sep;23(9):1127-37. doi: 10.1089/thy.2011.0421. Epub 2013 Aug 27.

PMID:
23617728
13.

N-Glycosylation pattern of recombinant human CD82 (KAI1), a tumor-associated membrane protein.

Wang H, Zhang W, Zhao J, Zhang L, Liu M, Yan G, Yao J, Yu H, Yang P.

J Proteomics. 2012 Feb 2;75(4):1375-85. doi: 10.1016/j.jprot.2011.11.013. Epub 2011 Nov 20.

PMID:
22123080
14.

KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.

Zhang BH, Liu W, Li L, Lu JG, Sun YN, Jin DJ, Xu XY.

Asian Pac J Cancer Prev. 2013;14(6):3521-6.

15.

Effect of expressional alteration of KAI1 on breast cancer cell growth, adhesion, migration and invasion.

Malik FA, Sanders AJ, Kayani MA, Jiang WG.

Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):205-13.

16.

Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.

Tang Y, Cheng Y, Martinka M, Ong CJ, Li G.

Carcinogenesis. 2014 Jan;35(1):86-95. doi: 10.1093/carcin/bgt346. Epub 2013 Oct 15.

17.

Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.

Li Y, Huang X, Zhang J, Li Y, Ma K.

Int J Biochem Cell Biol. 2013 Nov;45(11):2349-58. doi: 10.1016/j.biocel.2013.08.002. Epub 2013 Aug 19.

PMID:
23968914
18.

KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.

Liu W, Iiizumi-Gairani M, Okuda H, Kobayashi A, Watabe M, Pai SK, Pandey PR, Xing F, Fukuda K, Modur V, Hirota S, Suzuki K, Chiba T, Endo M, Sugai T, Watabe K.

J Biol Chem. 2011 May 27;286(21):18949-59. doi: 10.1074/jbc.M111.232637. Epub 2011 Mar 21.

19.

Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.

Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, Saito K, Pauza ME, Hayashi S, Wang Y, Mohinta S, Mashimo T, Iiizumi M, Furuta E, Watabe K.

Nat Med. 2006 Aug;12(8):933-8. Epub 2006 Jul 23.

PMID:
16862154
20.

KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.

Zhang B, Liu W, Li L, Lu J, Liu M, Sun Y, Jin D.

Int J Clin Exp Pathol. 2013 May 15;6(6):1060-7. Print 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk